SUPER HERBS 350 mg, 30 capsules per bottle.

FDA recall notice · announced June 1, 2016 · Super Herbs

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

SUPER HERBS 350 mg, 30 capsules per bottle.

Reason for recall

Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.

Notes

Distribution: 9 consignees - only 9 bottles distributed
Lot/code information: All lots
Quantity: 9 bottles
Status: Terminated
Products in this recall event:
- SUPER HERBS 350 mg, 30 capsules per bottle. (D-0909-2016)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.